|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Review On Remogliflozin Etabonate |
| Authors Name: | Sameer D Suryawanshi , Dr. S. P. Pawar , Mr. Amitkumar R. Dhankani , Mrs. Mansi A Dhankani |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_218871
|
| Published Paper Id: | IJNRD2404585 |
| Published In: | Volume 9 Issue 4, April-2024 |
| DOI: | |
| Abstract: | A recent addition to the class of SGLT-2 (sodium glucose cotransporter-2) inhibitors made available in India is remogliflozin. In comparison to other gliflozins, the medicine is introduced and sold at a cheaper price range. Because remogliflozin is less expensive than other gliflozins, it is anticipated to become more popular. Still, the It is still unclear if remogliflozin has any practical effect in establishing and preserving blood glucose control. The purpose of this study was to determine whether remogliflozin, as opposed to other gliflozin, is effective in helping individuals with type 2 diabetes maintain glycaemic control. A recent addition to the class of SGLT-2 (sodium glucose cotransporter-2) inhibitors made available in India is remogliflozin. In comparison to other gliflozins, the medicine is introduced and sold at a cheaper price range. Remogliflozin should increase in value. RE is a potent and selective inhibitor of SGLT2 with the unique distinction of being administered as a prodrug, existence of active metabolites, and short half-life necessitating twice-daily dosing. The Phase III study of RE demonstrated it to be an efficacious and safe agent and non-inferior to the currently available SGLT2 inhibitors. This paper reviews not only the pharmacokinetics, pharmacodynamics, clinical efficacy, and safety profile of RE but also its molecular and clinical development program This review has taken into consideration all available published as well as unpublished literature on RE and discusses the individual studies performed during its development for characterization of pharmacological profile. |
| Keywords: | Remogliflozin Etabonate,sodium-glucose cotransporter subtype 2 (SGLT2) ,type 2 diabetes mellitus (T2DM) |
| Cite Article: | "A Review On Remogliflozin Etabonate", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 4, page no.f699-f705, April-2024, Available :http://www.ijnrd.org/papers/IJNRD2404585.pdf |
| Downloads: | 00056 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2404585 Registration ID: 218871 Published In: Volume 9 Issue 4, April-2024 DOI (Digital Object Identifier): Page No: f699-f705 Country: Nandurbar, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2404585 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2404585 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn